Farther Finance Advisors’s iTeos Therapeutics ITOS Stock Holding History

Farther Finance Advisors’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-120	Closed	-$1.2K	–	5023
2025 Q2	$1.2K	Buy	+120	New	+$967	﹤0.01%	3858
2025 Q1	–	Sell	-19	Closed	-$146	–	4339
2024 Q4	$146	Sell	19 -15	-44%	-$129	﹤0.01%	3720
2024 Q3	$347	Buy	34 +19	+127%	+$290	﹤0.01%	3511
2024 Q2	$225	Hold	15	–	–	﹤0.01%	3475
2024 Q1	$200	Sell	15 -10	-40%	-$109	﹤0.01%	3276
2023 Q4	$274	Buy	+25	New	+$248	﹤0.01%	3154

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Farther Finance Advisors's ITOS Position: Q3 2025 in Review

Farther Finance Advisors sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 120 shares — an estimated $1.2K sold.

Farther Finance Advisors first reported a position in ITOS in Q4 2023 and held it in 6 quarters. The position peaked at $1.2K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Farther Finance Advisors reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Farther Finance Advisors sold 120 iTeos Therapeutics shares in Q3 2025, an estimated $1.2K.
Farther Finance Advisors first reported a position in iTeos Therapeutics in Q4 2023 and held it in 6 quarters.
Farther Finance Advisors's iTeos Therapeutics position peaked at $1.2K in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Farther Finance Advisors's 13F filing for Q3 2025, filed 14 Oct 2025.